NCPA - National Center for Policy Analysis

Daily Policy Digest

Utah Joins Oklahoma in Rejecting Clean Power Plan

The state of Utah has now joined Oklahoma in outright rejecting complying with the Clean Power Plan after the Supreme Court halted the regulations earlier in February...

MIT Researchers Say Health Care Loans Could Make Costly Drugs Affordable

MIT researchers discuss a novel way for patients to afford breakthrough medications they otherwise could not afford: health care loans...

Health Construction Still Very Weak in January

Construction of new health facilities remained very weak in January, shrinking 0.1 percent since December, while other construction grew at 1.6 percent...

Occupational Licensing Reform: Walk, Don't Run

In 1952, less than 5 percent of U.S. workers were required to be licensed to legally perform their jobs. By 2008, that number had risen to 29 percent, writes NCPA Senior Fellow Thomas Hemphill...

Will the Nation's Capital Have Universal School Choice?

Recently, U.S. Sen. Ted Cruz (R-Texas) introduced the Educational Freedom Accounts Act (S. 2455), creating a universal school choice program in Washington, D.C...

"Pricelessness" is Much More Than an Efficiency/Equity Trade-off Issue

Much less than a free market is an adequate first step towards transformational school system reform...

North Carolina Is on a Roll

North Carolina may have the opportunity for its citizens to vote on a referendum to reduce taxes and limit the growth of state spending...

Will Drug Companies' Price Firewall Melt?

A recent Kaiser Family Foundation Tracking Poll brings dire news for innovative drug companies: 83 percent of respondents favor a policy "allowing the federal government to negotiate drug prices for Medicare beneficiaries"...

Gross Domestic Product: Health Spending 29 Percent of Growth

Obamacare is not bending the cost curve...

Fast Track to Nowhere? Biological Intellectual Property in the Trans Pacific Partnership

The Trans Pacific Partnership is a free-trade deal between over a dozen countries which had bipartisan Congressional support. Unfortunately, President Obama's failure to protect intellectual property in biologic medicines has likely doomed the deal to failure...


« Last 8 « Newer « 18 19 20 21 22 23 24 25  Older »